Common Stock, Shares, Issued of TITAN PHARMACEUTICALS INC from 31 Dec 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
TITAN PHARMACEUTICALS INC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 30 Jun 2025.
  • TITAN PHARMACEUTICALS INC Common Stock, Shares, Issued for the quarter ending 30 Jun 2025 was 1,330,234, a 46% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

TITAN PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 1,330,234 +416,000 +46% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 914,234 0 0% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 914,234 +132,731 +17% 31 Dec 2024 10-Q 14 Aug 2025 2025 Q2
Q3 2024 914,234 -14,102,061 -94% 30 Sep 2024 10-Q 03 Jan 2025 2024 Q3
Q2 2024 914,234 -14,102,061 -94% 30 Jun 2024 10-Q 15 Aug 2024 2024 Q2
Q1 2024 914,234 -14,102,061 -94% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 781,503 +30,688 +4.1% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 15,016,295 +387,078 +2.6% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 15,016,295 +387,078 +2.6% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 15,016,295 +2,976,874 +25% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 750,815 -9,163,343 -92% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 14,629,217 +4,765,059 +48% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 14,629,217 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 12,039,421 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 9,914,158 +2,775,090 +39% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 9,864,158 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q4 2020 7,139,068 +5,226,441 +273% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q4 2019 1,912,627 -11,097,665 -85% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 17,114,000 -22,253,744 -57% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 14,262,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q4 2018 13,010,292 +9,476,334 +268% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 39,367,744 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q4 2017 3,533,958 -17,664,921 -83% 31 Dec 2017 10-K/A 02 Apr 2019 2018 FY
Q4 2016 21,198,879 +1,139,059 +5.7% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 20,059,820 +60,268 +0.3% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 19,999,552 -68,794,670 -77% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 88,794,222 +13,578,509 +18% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q4 2012 75,215,713 +15,829,171 +27% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q4 2011 59,386,542 +138,800 +0.23% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q4 2010 59,247,742 31 Dec 2010 10-K 15 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.